**5. Conclusion**

Performing ablation in patients with a concomitant correction of aortic valve disease is not associated with increased in-hospital mortality, more frequent pacemaker implantation or neurological complications and is indicated for all patients diagnosed with arrhythmia. Combined open procedures show significantly better long-term outcomes than isolated transcatheter aortic valve implantation in elderly patients with low surgical risk and persistent atrial fibrillation. An analysis conducted by William L Patrick et al. demonstrates reduced mortality, pacemaker implantation rates, and hospitalizations due to decompensated heart failure in the long-term period for patients who underwent arrhythmia correction and prosthetic valve replacement under cardiopulmonary bypass, compared to the transcatheter aortic valve implantation group (TAVI) group where ablation was not performed [44].

We again emphasize that the choice of ablation protocol depends on the form of atrial fibrillation, the patient's atrial size, and concomitant pathology. According to the authors, the ablation protocol presented in this chapter is appropriate for most clinical situations.

*Surgical Treatment of Patients with Aortic Valve Disease in Association with Atrial Fibrillation DOI: http://dx.doi.org/10.5772/intechopen.112888*
